Treatment of inflammatory bowel disease

• US 20030119824A1
• Filed: 12/19/2002
• Published: 06/26/2003
• Est. Priority Date: 01/05/2000
• Status: Abandoned Application

• Current Assignee: Redmond H. Paul, Rolf W. Pfirrmann
• Original Assignee: Redmond H. Paul, Rolf W. Pfirrmann
• Inventors: Redmond, H. Paul, Pfirrmann, Rolf W.
• Application Number:
  US10/322,747
• Publication Number:
  US 20030119824A1
• Time in Patent Office: Days
• US Class Current: 514/223.8
• CPC Class Codes: A61K 31/00 Medicinal preparations containing organic active ingredients
• CPC Class Codes: A61K 31/549 having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide
• CPC Class Codes: A61P 1/00 Drugs for disorders of the alimentary tract or the digestive system
• CPC Class Codes: A61P 1/04 for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Abstract

Patients suffering from inflammatory bowel disease such as Crohn'"'"'s disease or ulcerative colitis are treated either orally or intravenously with methylol transfer agents, such as taurolidine and/or taurultam. These agents can be used in combination with other drugs thereby allowing the use of smaller amounts of the other drugs and limiting unwanted side effects.

Claims

1. A method of treating a human infected with Crohn'"'"'s disease comprising orally administering to an individual in need of such treatment an effective amount of a composition comprising taurolidine.

2. A method according to claim 1 wherein the composition is in suspension form.